JPH0232007A - Hair tonic - Google Patents
Hair tonicInfo
- Publication number
- JPH0232007A JPH0232007A JP18022788A JP18022788A JPH0232007A JP H0232007 A JPH0232007 A JP H0232007A JP 18022788 A JP18022788 A JP 18022788A JP 18022788 A JP18022788 A JP 18022788A JP H0232007 A JPH0232007 A JP H0232007A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- tonic
- nicorandil
- effects
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 36
- 230000001256 tonic effect Effects 0.000 title abstract description 10
- LBHIOVVIQHSOQN-UHFFFAOYSA-N nicorandil Chemical compound [O-][N+](=O)OCCNC(=O)C1=CC=CN=C1 LBHIOVVIQHSOQN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960002497 nicorandil Drugs 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 2
- -1 N-(2hydroxyethyl)nicotinic acid amide nitrate ester Chemical class 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 4
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000003405 preventing effect Effects 0.000 abstract 2
- 238000002156 mixing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 230000003779 hair growth Effects 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 201000004384 Alopecia Diseases 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 6
- 208000024963 hair loss Diseases 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000003797 telogen phase Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 3
- 230000003660 hair regeneration Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 229930007845 β-thujaplicin Natural products 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- 229960002326 bithionol Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野〕
本発明は、ニコランジルを有効成分とする新規な養毛剤
に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a novel hair nourishing agent containing nicorandil as an active ingredient.
[従来の技術]
従来、禿や脱毛の原因としては、毛根、皮脂腺等の諸室
における男性ホルモンの活性化、毛包への血流量の低下
、皮脂の分泌過剰、過酸化物の生成、細菌の繁殖等によ
る頭皮の異常、遺伝的要素、ストレス等による神経症、
疾病による二次的なものおよび老化等が考えられている
。[Prior Art] Conventionally, the causes of baldness and hair loss include activation of male hormones in various chambers such as hair roots and sebaceous glands, decreased blood flow to hair follicles, excessive secretion of sebum, production of peroxide, and bacteria. Scalp abnormalities due to breeding, genetic factors, neurosis due to stress, etc.
It is thought to be secondary to disease and aging.
このため、従来の養毛剤には、前記の原因を取り除いた
り、または軽減する作用をもつ化合物が一般に配合され
ている。For this reason, conventional hair growth agents generally contain compounds that have the effect of eliminating or alleviating the above-mentioned causes.
一方二コランジルは冠血管拡張作用、冠動脈堂縮抑制作
用を有し、心血性動態および心機能に及ぼす影響の少な
い各種病型の狭心症治療薬として有効な薬物である(特
公昭58−17463号。On the other hand, nicorandil has a coronary vasodilatory effect and an inhibitory effect on coronary artery constriction, and is an effective drug for treating various types of angina pectoris with little effect on cardiovascular dynamics and cardiac function. issue.
特開昭53−9323号)。JP-A No. 53-9323).
[発明が解決しようとする護国1
前記のような試みがなされているにも拘らず、脱毛や発
毛の機構は非常に複雑であり、単に男性ホルモンの活性
化を阻害したり、毛包の血流量を増加させるだけでは禿
や脱毛を充分に防止することはできない。[Protecting the country that the invention seeks to solve 1 Despite the above-mentioned attempts, the mechanism of hair loss and hair growth is extremely complex, and it is difficult to simply inhibit the activation of male hormones or to inhibit the growth of hair follicles. Simply increasing blood flow cannot sufficiently prevent baldness and hair loss.
本発明者等は、上記の事情に鑑み、脱毛に対して有効な
防止作用をもつ物質を得るべく鋭意研究を重ねた結果、
ニコランジルがほれた養毛作用を有するという新規な事
実を見出し、この知見に基づいて本発明を完成するに至
った。In view of the above circumstances, the present inventors have conducted intensive research to obtain a substance that has an effective preventive effect against hair loss, and as a result,
We have discovered a novel fact that nicorandil has a hair-nourishing effect, and have completed the present invention based on this knowledge.
[課題を解決するための手段および作用]即ち、本発明
はニコランジルを有効成分とする養毛剤を要旨とするも
のである。以下本発明に1いて更に詳しく説明する。[Means and effects for solving the problems] That is, the gist of the present invention is a hair nourishing agent containing nicorandil as an active ingredient. The present invention will be explained in more detail below.
本発明におけるニコランジルは本邦で発明開発された(
永野洋幸はか1日本薬学会第98回抄録集、232.1
978)狭心症治療薬である。その薬理作用は循環器系
に関しては多数の報告がなされているが、その他の部位
については臨床用量の100倍以上量を投与した場合に
中枢神経系および腎機能Jこ軽度な変化を示したという
報告がなされているだけで養毛作用をもつことは勿論知
られていない。Nicorandil in the present invention was invented and developed in Japan (
Hiroyuki Nagano Haka1 98th Abstracts of the Pharmaceutical Society of Japan, 232.1
978) It is a drug for treating angina pectoris. Many reports have been made regarding its pharmacological effects on the circulatory system, but it has been reported that administration of doses 100 times or more of the clinical dose showed mild changes in the central nervous system and renal function. Of course, it is not known that it has a hair-nourishing effect, although it has only been reported.
本明細書において「養毛効果」または「養毛作用」とは
、脱毛予防、毛虫および発毛の促進ならびに育毛を意味
する。As used herein, "hair nourishing effect" or "hair nourishing effect" means prevention of hair loss, promotion of caterpillars and hair growth, and hair growth.
本発明の養毛剤は、ニコランジルの他に、製薬上許容す
ることのできる添加剤および他の薬剤を加えた混合物の
形で使用する。The hair growth agent of the present invention is used in the form of a mixture containing pharmaceutically acceptable additives and other drugs in addition to nicorandil.
前記の添加剤としては、例えば、ヒノキチオール、ヘキ
サクロロフェン、フェノール、塩化ベンザルコニウム、
セチルピリジニウムクロリド、ウンデシレン酸、トリク
ロロカルバニリドおよびビチオノール等の抗菌剤、グリ
チルリチン酸およびそのアンモニウム塩等の誘導体、ア
ラントイン、メントール等の消炎或は清涼剤、サリチル
酸、亜鉛およびその化合物、乳酸およびそのアルキルエ
ステル等の薬剤、オリーブ油、マカデミアナツツ油、ス
クワラン等の動植物油、流動パラフィンに代表される炭
化水素油、イソプロピルミリステート、セチルイソオク
タノエート、2−エチルへキシルパルミテート等のエス
テル油、ミツロウ等のワックス類、高級脂肪酸、高級ア
ルコール等の油分、水、乳酸およびそのエチルエステル
等の誘導体、ポリエチレングリコール、グリセリン、ソ
ルビトール等の多価アルコール、エタノール等の低級ア
ルコール、ムコ多糖想、ピロリドンカルボン酸塩等の保
湿剤、界面活性剤、香料、酸化防止剤、紫外線吸収剤、
色素等を挙げることができ、これらを1種、または2種
以上混合して使用する。Examples of the additives include hinokitiol, hexachlorophene, phenol, benzalkonium chloride,
Antibacterial agents such as cetylpyridinium chloride, undecylenic acid, trichlorocarbanilide and bithionol, derivatives such as glycyrrhizinic acid and its ammonium salts, anti-inflammatory or cooling agents such as allantoin and menthol, salicylic acid, zinc and its compounds, lactic acid and its alkyl Drugs such as esters, animal and vegetable oils such as olive oil, macadamia nut oil, and squalane, hydrocarbon oils such as liquid paraffin, ester oils such as isopropyl myristate, cetyl isooctanoate, and 2-ethylhexyl palmitate, and beeswax. Waxes such as, higher fatty acids, oils such as higher alcohols, water, derivatives such as lactic acid and its ethyl ester, polyhydric alcohols such as polyethylene glycol, glycerin, sorbitol, lower alcohols such as ethanol, mucopolysaccharides, pyrrolidone carboxylic acid Moisturizing agents such as salt, surfactants, fragrances, antioxidants, ultraviolet absorbers,
Examples include pigments, and these may be used alone or in combination of two or more.
本発明の養毛剤の剤型ば、外用できるものであれば任意
の形態でよく、例えば、ローション、リニメント、乳液
等の外用液剤、クリーム、軟膏、パスタ、ゼリー、スプ
レー等の外用半固型剤等を挙げることができる。The dosage form of the hair tonic of the present invention may be any form as long as it can be used externally, such as liquid preparations for external use such as lotions, liniments, milky lotions, semi-solid preparations for external use such as creams, ointments, pasta, jelly, sprays, etc. can be mentioned.
本発明の養毛剤には、有効成分であるニコランジルを0
.001〜10重量%、好ましくは0.01〜5重量%
の範囲で含有きせる。The hair tonic of the present invention contains 0 nicorandil as an active ingredient.
.. 001-10% by weight, preferably 0.01-5% by weight
Contains within the range of .
本発明の養毛剤は、皮膚に直接塗布または散布する経皮
投与による投与方法をとる。また、本発明の養毛剤の投
与量は、年齢、個人差、病状等によって変化するので明
確には規定できないが、−般に人を対象とする場合、ニ
コランジルの経皮投与量は体重I Kgおよび1日当り
0.0001〜20 mg好ましくはo、ooi〜2
mgであり、この量を10に1回または2〜4回に分け
て投与することかでさ−る。The hair growth agent of the present invention is administered by transdermal administration, in which it is directly applied or sprayed onto the skin. Furthermore, the dosage of the hair tonic of the present invention cannot be clearly defined as it varies depending on age, individual differences, medical conditions, etc.; however, in general, when targeting humans, the transdermal dosage of nicorandil is based on body weight I kg and 0.0001-20 mg per day preferably o,ooi-2
mg, and this amount can be administered once every 10 times or divided into 2 to 4 times.
以下に実施例を示して本発明による養毛剤の製剤化方法
および養毛効果を具体的に説明する。なお本発明はこれ
により限定されるものではない。EXAMPLES Below, the formulation method of the hair growth agent and the hair growth effect according to the present invention will be specifically explained with reference to Examples. Note that the present invention is not limited to this.
1皇五−よ− 以下の組成からなるローションを調製した。1 Kogo-yo- A lotion having the following composition was prepared.
(重量%)
95%エタノール 80.0ニコラン
ジル 0・1ヒノキチオール
0.01硬化ヒマシ油のエチレンオキ
シド 0.5(40モル)付加物
精製水 19.0香料およ
び色素 適量95%エタノールにニコ
ランジル、ヒノキチオール、硬化ヒマシ油のエチレンオ
キシド(40モル)付加物、香料および色素を加えて攪
拌溶解し、次いで精製水を加えて透明液状のローション
を得た。(Weight%) 95% ethanol 80.0 nicorandil 0.1 hinokitiol
0.01 Ethylene oxide adduct of hydrogenated castor oil 0.5 (40 mol) Purified water 19.0 Fragrance and pigment Appropriate amount of nicorandil, hinokitiol, ethylene oxide (40 mol) adduct of hydrogenated castor oil, fragrance and pigment in 95% ethanol. Then, purified water was added to obtain a transparent liquid lotion.
1」]」u【1匹
本発明の養毛剤の養毛作用を調べるために、トリコグラ
ム試験および終毛転換率試馳を実施した。両試馴におい
て、男性被験者20名ずつをそれぞれ10名ずつの2つ
の群に分け、各群の被験者ごとに異なる2種の試験液を
与えて比較した。1"]"u [1 animal In order to investigate the hair-growth effect of the hair-growth agent of the present invention, a tricogram test and a trial of terminal hair conversion rate were conducted. In both trials, 20 male subjects were divided into two groups of 10 subjects each, and two different test solutions were given to the subjects in each group for comparison.
2種の試験液を表1に示す。Two types of test solutions are shown in Table 1.
布置前および直後に各々抜去した毛根を被験者1名につ
キロ0本ずつ調べた。結果を表2に示す。0 kg of hair roots were removed per subject and examined immediately after and before placement. The results are shown in Table 2.
者の頭皮に塗布した。applied to the scalp of a person.
(1) トリコグラム
前記の両試験液の使用前および使用後の抜去毛髪の毛根
を顕wI鏡下で観察し、毛根の形態から休止期毛根数を
計算し、その割合の増減によって両試験液の養毛効果を
比較した。休止期毛根とは、成長の止まった毛の毛根で
ある。脱毛を訴える人は、この休止期毛根の数が正常の
人よりも多いので、この休止期毛根の減少から養毛効果
を評価した。各試!!!液の頭皮への塗布を3か月継続
し、塗(2)紡毛転換率試験
男性型脱毛症の被験者40名の各々の頭部うぶ毛部位3
か所において、前記の各試験液の塗布前後における、う
ぶ毛から綿毛への転換率を比較した。綿毛どはうぶ毛以
外の毛、すなわち長き14 mm以上の毛をいい、うぶ
毛から綿毛への転換は養毛効果を意味する。各試験液の
塗布直前および4か月塗布終了直後に、前記の頭部うぶ
毛部位を接写写真撮影して転換率を測定した。綿毛への
転換率は3か所の平均をパーセントで示した。結果を表
3に示す。(1) Trichogram Observe the removed hair roots before and after using both test solutions above under a microscope, calculate the number of telogen hair roots from the morphology of the hair roots, and calculate the difference between the two test solutions by increasing or decreasing the ratio. We compared the hair growth effects of A telogen hair root is a hair root that has stopped growing. People who complain of hair loss have more telogen hair roots than normal people, so the hair-nourishing effect was evaluated based on the decrease in telogen hair roots. Each trial! ! ! The solution was continued to be applied to the scalp for 3 months, and (2) Hair conversion rate test was applied to the down hair area of each of the 40 subjects with androgenetic alopecia.
The conversion rate of downy hair to fluff was compared before and after application of each of the above test solutions. Fluff refers to hair other than downy hair, that is, long hair of 14 mm or more, and the conversion from downy hair to downy hair means a hair-nourishing effect. Immediately after application of each test solution and immediately after completion of the 4-month application, close-up photographs of the above-mentioned down hair region of the head were taken to measure the conversion rate. The conversion rate to fluff is expressed as a percentage of the average of the three locations. The results are shown in Table 3.
化率の平均値を求めた。28日後毛再生面鎖の結果を百
分率にて表4に示した。The average value of conversion rate was calculated. The results of the hair regeneration surface chain after 28 days are shown in Table 4 as a percentage.
(3)育毛効果の測定(マウスによる方法)雄のC3H
マウス(生後50日)を用い、小川らの方法(M、5e
ijiほか編集、Norm−al and Abn
ormal Epide−rmal Differ
entiation、東大出版会)に準じ実験を行なっ
た。マウスの背部上を約2X4cmの大ぎきに刈り、翌
日より1日1回ずつ連日試料の塗布を行ない、毛再生が
始まった部分の面積比の変化を求め、毛再生の速ざを比
較した。ニコランジルは90%エタノールに溶解した。(3) Measurement of hair growth effect (method using mice) Male C3H
Using mice (50 days old), Ogawa et al.'s method (M, 5e
Edited by iji et al., Norm-al and Abn
normal Epide-rmal Differ
The experiment was conducted in accordance with the publication published by the University of Tokyo Press. The backs of the mice were shaved into a large piece of about 2 x 4 cm, and the sample was applied once a day from the next day. Changes in the area ratio of the area where hair regeneration had started were determined and the speed of hair regeneration was compared. Nicorandil was dissolved in 90% ethanol.
試験には対照として90%エタノールを用いた。各群1
0匹ずつのマウスを用い、その変以上の結果から明らか
なように、ニコランジルは優れた養毛効果を示すことが
判明した。90% ethanol was used as a control in the test. Each group 1
Using 0 mice each, it was found that nicorandil exhibits an excellent hair growth effect, as is clear from the results above average.
以下にその池の実施例を示すが、いずれも同様の実便用
テストの結果、脱毛防止、養毛に優れた効果を示した。Examples of the ponds are shown below, and as a result of similar practical tests, all of them showed excellent effects on hair loss prevention and hair growth.
また本発明はこれに限定されるものではない。Moreover, the present invention is not limited to this.
スJJL−二一 へアートニック (重量%)ニ
コランジル 0.1ラウリ
ルジメチルアミンオキシド 0.5ラウリル硫酸
ナトリウム
プロピレングリコール
ヒアルロン酸ナトリウム
香料
75%エタノール
」コ1童り一3.ヘアートニック
ニコランジル
ポリオキシエチレン(8モル)
オレイルアルコールエーテル
1.3−ブチレングリコール
香料
60%エタノール
裏厳五−互一 シャンプー
ニコランジル
ココイルメチルタウリンナトリウム
ラウリルジメチルアミノ酢酸ベタイン
ラウリン酸ジェタノールアミド
エチレングリコール脂肪酸エステル
0.05
5.0
0.01
適量
残余
(li量%)
0.01
0.05
0.05
適量
残余
(重量%)
0.05
1.0
8.0
4.0
1.5
プロピレングリコール
エデト酸2ナトリウム
香料
精製水
1已叛IL−5,リンス
ニコランジル
スケアリルトリメチルアンモニウム
クロリド
セチルアルコール
シリコン油
ポリオキシエチレン(10モル)
オレイルアルコールエーテル
グリセリン
精製水
防腐剤
紫外線吸収剤
2.0
0.1
適量
残余
(重量%)
0.001
2.0
2.0
3.0
1.0
5.0
84.0
適量
適量
(以下余白)
[発明の効果]
本発明は以上説明したように構成きれているので、以下
に記載されるような効果を奏する。SJJL-21 Hair Tonic (% by weight) Nicorandil 0.1 Lauryl dimethylamine oxide 0.5 Sodium lauryl sulfate Propylene glycol Sodium hyaluronate Fragrance 75% Ethanol Hair Tonic Nicorandyl Polyoxyethylene (8 mol) Oleyl Alcohol Ether 1.3-Butylene Glycol Fragrance 60% Ethanol Uragengo-Kouichi Shampoo Nicorandyl Cocoyl Methyl Taurine Sodium Lauryl Dimethyl Amino Acetate Betaine Lauric Acid Jetanolamide Ethylene Glycol Fatty Acid Ester 0 .05 5.0 0.01 Proper amount remaining (li amount%) 0.01 0.05 0.05 Proper amount remaining (weight%) 0.05 1.0 8.0 4.0 1.5 Propylene glycol edetic acid 2 Sodium Flavor Purified Water 1 已发IL-5, Rinse Nicorandyl Skearyl Trimethyl Ammonium Chloride Cetyl Alcohol Silicone Oil Polyoxyethylene (10 mol) Oleyl Alcohol Ether Glycerin Purified Water Preservative Ultraviolet Absorber 2.0 0.1 Appropriate amount remaining (weight) %) 0.001 2.0 2.0 3.0 1.0 5.0 84.0 Appropriate amount Appropriate amount (hereinafter referred to as the margin) [Effects of the invention] Since the present invention has been configured as described above, the following will be explained below. It produces the effects described.
請求項記載の発明によれば、養毛剤にニコランジルを配
合したので、従来の同種の化粧料よりも著しく潰れた脱
毛防止効果、養毛効果を示す。According to the claimed invention, since nicorandil is blended into the hair growth agent, the hair growth prevention effect and hair growth effect are significantly greater than that of conventional cosmetics of the same type.
特許出願人 株式会社 資 生 堂Patent applicant Shiseido Co., Ltd.
Claims (1)
ミド硝酸エステル(一般名:ニコランジル)または、そ
の塩類を有効成分とする養毛剤。[Claims] N-(2-hydroxyethyl)nicotinamide nitrate (generic name: nicorandil) represented by the following structural formula ▲ Numerical formula, chemical formula, table, etc. ▼ or its salts as an active ingredient Hair nourishing agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18022788A JPH0232007A (en) | 1988-07-21 | 1988-07-21 | Hair tonic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18022788A JPH0232007A (en) | 1988-07-21 | 1988-07-21 | Hair tonic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0232007A true JPH0232007A (en) | 1990-02-01 |
Family
ID=16079604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18022788A Pending JPH0232007A (en) | 1988-07-21 | 1988-07-21 | Hair tonic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0232007A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303722C (en) * | 1997-03-24 | 2007-03-07 | 松下电器产业株式会社 | End plate incorporated in battery power source unit and cooling device for battery power source |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02501570A (en) * | 1986-12-12 | 1990-05-31 | ジ・アップジョン・カンパニー | Use of nicorandil to treat alopecia |
-
1988
- 1988-07-21 JP JP18022788A patent/JPH0232007A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02501570A (en) * | 1986-12-12 | 1990-05-31 | ジ・アップジョン・カンパニー | Use of nicorandil to treat alopecia |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303722C (en) * | 1997-03-24 | 2007-03-07 | 松下电器产业株式会社 | End plate incorporated in battery power source unit and cooling device for battery power source |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07316023A (en) | Hair tonic | |
CA2761732C (en) | Composition for preventing hair loss or for stimulating hair growth | |
KR100564386B1 (en) | A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3-3-methyl-2-butenyl-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one | |
JPH10212225A (en) | Wrinkle preventive | |
JPH03112912A (en) | Cosmetic composition | |
JPS6219513A (en) | Hair tonic | |
US6288112B1 (en) | Use of pyrethroid compounds to promote hair growth | |
JPH0232007A (en) | Hair tonic | |
JPH09241137A (en) | Hair crowing and restoring agent | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JPS6219512A (en) | Hair tonic | |
JPH10265365A (en) | External preparation for skin for pimple | |
US5720946A (en) | Hair revitalizing composition containing two or more amine oxides having different chain links | |
JPH11302131A (en) | Cosmetic for scalp and hair | |
JP3542700B2 (en) | Head composition | |
JP2787451B2 (en) | Hair restoration | |
JPH07149614A (en) | Hair tonic agent | |
JP2814090B2 (en) | Hair restoration | |
JP3529117B2 (en) | Hair restoration composition | |
JPH10245393A (en) | Composition containing triterpenes | |
JP2961528B2 (en) | Hair restoration | |
JPH01238515A (en) | Hair tonic | |
JPS6344511A (en) | Hair tonic | |
JPH10273422A (en) | Cosmetic for hair | |
JPH01268623A (en) | Hair tonic |